Oncology's first Phase 0 trial.
Rowan
Karen
K
D000970:Antineoplastic Agents / Q000009:adverse effects / Q000494:pharmacology; D002986:Clinical Trials as Topic / Q000379:methods / Q000639:trends; D017321:Clinical Trials, Phase I as Topic; D017322:Clinical Trials, Phase II as Topic; D017326:Clinical Trials, Phase III as Topic; D032882:Comprehension; D017277:Drug Approval / Q000458:organization & administration*; D015507:Drugs, Investigational; D006801:Humans; D054547:National Cancer Institute (U.S.); D010361:Patients / Q000523:psychology; D014481:United States; D014486:United States Food and Drug Administration
D000970:Antineoplastic Agents; D015507:Drugs, Investigational